Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Related keylists
Gamida Cell Ltd (Gamida), a subsidiary of Ayrmid Ltd, is a healthcare company that develops allogeneic cell therapy products and candidates. Its proprietary nicotinamide (NAM) technology enhances and expands cells, creating allogeneic cell therapy products and candidates for patients with hematologic malignancies. The company's pipeline products include omidubicel which treats hematologic malignancies and severe aplastic anemia and GDA-201 which is a natural killer (NK) cell therapy candidate for the treatment of non-hodgkin lymphoma. Its brand includes Omisirge. The company collaborates with advocacy organizations. It operates in Israel and the US. Gamida is headquartered in Kiryat Gat, Israel.
Headquarters
Israel
Address
12 Leshem Street, Kiryat Gat, 82584120
Website
www.gamida-cell.com
Telephone
972 073 2064774
No of Employees
145
Industry
Pharmaceuticals and Healthcare
Revenue (2023)
$1.8M
Gamida Cell Ltd premium industry data and analytics
Products and Services
| Products | Services | Brands |
|---|---|---|
| Omidubicel - Hematologic Malignancies and Severe Aplastic Anemia | Cell Therapies | Omisirge |
| GDA-201 - Non-Hodgkin Lymphoma |
Competitor Comparison
| Key Parameters | Gamida Cell Ltd | MediPost Co Ltd | Fate Therapeutics Inc | Dianthus Therapeutics Inc | Bellicum Pharmaceuticals Inc |
|---|---|---|---|---|---|
| Headquarters | Israel | South Korea | United States of America | United States of America | United States of America |
| City | Kiryat Gat | Seongnam | San Diego | New York City | Houston |
| State/Province | - | - | California | New York | Texas |
| No. of Employees | 145 | 209 | 161 | 92 | 13 |
| Entity Type | Private | Public | Public | Public | Private |
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Joe Wiley | Chief Executive Officer | Senior Management | 2024 | - |
| Terry Coelho | Chief Financial Officer | Senior Management | 2023 | - |
| Rory Nealon | Chief Operating Officer | Senior Management | - | - |
| Ronit Simantov, M.D. | Chief Medical Officer; Chief Scientific Officer | Senior Management | 2017 | - |
| Peter McMahon | Chief Human Resources Officer | Senior Management | - | - |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer